Cargando…
The Oslo Ischaemia Study: cohort profile
PURPOSE: The Oslo Ischaemia Study was designed to investigate the prevalence and predictors of silent coronary disease in Norwegian middle-aged men, specifically validating exercise electrocardiography (ECG) findings compared with angiography. The study has been important in investigating long-term...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515426/ https://www.ncbi.nlm.nih.gov/pubmed/34645662 http://dx.doi.org/10.1136/bmjopen-2021-049111 |
_version_ | 1784583610816266240 |
---|---|
author | Falk, Ragnhild Sørum Mariampillai, Julian Eek Prestgaard, Erik Edvard Heir, Trond Bodegård, Johan Robsahm, Trude Eid Grundvold, Irene Skretteberg, Per Torger Engeseth, Kristian Bjornholt, Jorgen Vildershoj Stavem, Knut Liestøl, Knut Sandvik, Leiv Thaulow, Erik Erikssen, Gunnar Kjeldsen, Sverre E Gjesdal, Knut Erikssen, Jan E |
author_facet | Falk, Ragnhild Sørum Mariampillai, Julian Eek Prestgaard, Erik Edvard Heir, Trond Bodegård, Johan Robsahm, Trude Eid Grundvold, Irene Skretteberg, Per Torger Engeseth, Kristian Bjornholt, Jorgen Vildershoj Stavem, Knut Liestøl, Knut Sandvik, Leiv Thaulow, Erik Erikssen, Gunnar Kjeldsen, Sverre E Gjesdal, Knut Erikssen, Jan E |
author_sort | Falk, Ragnhild Sørum |
collection | PubMed |
description | PURPOSE: The Oslo Ischaemia Study was designed to investigate the prevalence and predictors of silent coronary disease in Norwegian middle-aged men, specifically validating exercise electrocardiography (ECG) findings compared with angiography. The study has been important in investigating long-term predictors of cardiovascular morbidity and mortality, as well as investigating a broad spectrum of epidemiological and public health perspectives. PARTICIPANTS: In 1972–1975, 2014 healthy men, 40–59 years old, were enrolled in the study. Comprehensive clinical examination included an ECG-monitored exercise test at baseline and follow-ups. The cohort has been re-examined four times during 20 years. Linkage to health records and national health registries has ensured complete endpoint registration of morbidity until the end of 2006, and cancer and mortality until the end of 2017. FINDINGS TO DATE: The early study results provided new evidence, as many participants with a positive exercise ECG, but no chest pain (‘silent ischaemia’), did not have significant coronary artery stenosis after all. Still, they were over-represented with coronary disease after years of follow-up. Furthermore, participants with the highest physical fitness had lower risk of cardiovascular disease, and the magnitude of blood pressure responses to moderate exercise was shown to influence the risk of cardiovascular disease and mortality. With time, follow-up data allowed the scope of research to expand into other fields of medicine, with the aim of investigating predictors and the importance of lifestyle and risk factors. FUTURE PLANS: Recently, the Oslo Ischaemia Study has been found worthy, as the first scientific study, to be preserved by The National Archives of Norway. All the study material will be digitised, free to use and accessible for all. In 2030, the Oslo Ischaemia Study will be linked to the Norwegian Cause of Death Registry to obtain complete follow-up to death. Thus, a broad spectrum of additional opportunities opens. |
format | Online Article Text |
id | pubmed-8515426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-85154262021-10-27 The Oslo Ischaemia Study: cohort profile Falk, Ragnhild Sørum Mariampillai, Julian Eek Prestgaard, Erik Edvard Heir, Trond Bodegård, Johan Robsahm, Trude Eid Grundvold, Irene Skretteberg, Per Torger Engeseth, Kristian Bjornholt, Jorgen Vildershoj Stavem, Knut Liestøl, Knut Sandvik, Leiv Thaulow, Erik Erikssen, Gunnar Kjeldsen, Sverre E Gjesdal, Knut Erikssen, Jan E BMJ Open Cardiovascular Medicine PURPOSE: The Oslo Ischaemia Study was designed to investigate the prevalence and predictors of silent coronary disease in Norwegian middle-aged men, specifically validating exercise electrocardiography (ECG) findings compared with angiography. The study has been important in investigating long-term predictors of cardiovascular morbidity and mortality, as well as investigating a broad spectrum of epidemiological and public health perspectives. PARTICIPANTS: In 1972–1975, 2014 healthy men, 40–59 years old, were enrolled in the study. Comprehensive clinical examination included an ECG-monitored exercise test at baseline and follow-ups. The cohort has been re-examined four times during 20 years. Linkage to health records and national health registries has ensured complete endpoint registration of morbidity until the end of 2006, and cancer and mortality until the end of 2017. FINDINGS TO DATE: The early study results provided new evidence, as many participants with a positive exercise ECG, but no chest pain (‘silent ischaemia’), did not have significant coronary artery stenosis after all. Still, they were over-represented with coronary disease after years of follow-up. Furthermore, participants with the highest physical fitness had lower risk of cardiovascular disease, and the magnitude of blood pressure responses to moderate exercise was shown to influence the risk of cardiovascular disease and mortality. With time, follow-up data allowed the scope of research to expand into other fields of medicine, with the aim of investigating predictors and the importance of lifestyle and risk factors. FUTURE PLANS: Recently, the Oslo Ischaemia Study has been found worthy, as the first scientific study, to be preserved by The National Archives of Norway. All the study material will be digitised, free to use and accessible for all. In 2030, the Oslo Ischaemia Study will be linked to the Norwegian Cause of Death Registry to obtain complete follow-up to death. Thus, a broad spectrum of additional opportunities opens. BMJ Publishing Group 2021-10-13 /pmc/articles/PMC8515426/ /pubmed/34645662 http://dx.doi.org/10.1136/bmjopen-2021-049111 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Cardiovascular Medicine Falk, Ragnhild Sørum Mariampillai, Julian Eek Prestgaard, Erik Edvard Heir, Trond Bodegård, Johan Robsahm, Trude Eid Grundvold, Irene Skretteberg, Per Torger Engeseth, Kristian Bjornholt, Jorgen Vildershoj Stavem, Knut Liestøl, Knut Sandvik, Leiv Thaulow, Erik Erikssen, Gunnar Kjeldsen, Sverre E Gjesdal, Knut Erikssen, Jan E The Oslo Ischaemia Study: cohort profile |
title | The Oslo Ischaemia Study: cohort profile |
title_full | The Oslo Ischaemia Study: cohort profile |
title_fullStr | The Oslo Ischaemia Study: cohort profile |
title_full_unstemmed | The Oslo Ischaemia Study: cohort profile |
title_short | The Oslo Ischaemia Study: cohort profile |
title_sort | oslo ischaemia study: cohort profile |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515426/ https://www.ncbi.nlm.nih.gov/pubmed/34645662 http://dx.doi.org/10.1136/bmjopen-2021-049111 |
work_keys_str_mv | AT falkragnhildsørum theosloischaemiastudycohortprofile AT mariampillaijulianeek theosloischaemiastudycohortprofile AT prestgaarderikedvard theosloischaemiastudycohortprofile AT heirtrond theosloischaemiastudycohortprofile AT bodegardjohan theosloischaemiastudycohortprofile AT robsahmtrudeeid theosloischaemiastudycohortprofile AT grundvoldirene theosloischaemiastudycohortprofile AT skrettebergpertorger theosloischaemiastudycohortprofile AT engesethkristian theosloischaemiastudycohortprofile AT bjornholtjorgenvildershoj theosloischaemiastudycohortprofile AT stavemknut theosloischaemiastudycohortprofile AT liestølknut theosloischaemiastudycohortprofile AT sandvikleiv theosloischaemiastudycohortprofile AT thaulowerik theosloischaemiastudycohortprofile AT erikssengunnar theosloischaemiastudycohortprofile AT kjeldsensverree theosloischaemiastudycohortprofile AT gjesdalknut theosloischaemiastudycohortprofile AT erikssenjane theosloischaemiastudycohortprofile AT falkragnhildsørum osloischaemiastudycohortprofile AT mariampillaijulianeek osloischaemiastudycohortprofile AT prestgaarderikedvard osloischaemiastudycohortprofile AT heirtrond osloischaemiastudycohortprofile AT bodegardjohan osloischaemiastudycohortprofile AT robsahmtrudeeid osloischaemiastudycohortprofile AT grundvoldirene osloischaemiastudycohortprofile AT skrettebergpertorger osloischaemiastudycohortprofile AT engesethkristian osloischaemiastudycohortprofile AT bjornholtjorgenvildershoj osloischaemiastudycohortprofile AT stavemknut osloischaemiastudycohortprofile AT liestølknut osloischaemiastudycohortprofile AT sandvikleiv osloischaemiastudycohortprofile AT thaulowerik osloischaemiastudycohortprofile AT erikssengunnar osloischaemiastudycohortprofile AT kjeldsensverree osloischaemiastudycohortprofile AT gjesdalknut osloischaemiastudycohortprofile AT erikssenjane osloischaemiastudycohortprofile |